Product Images Frovatriptan Succinate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Frovatriptan Succinate NDC 0603-3718 by Par Pharmaceutical, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - frovatriptan succinate 1
Figure 1 - frovatriptan succinate 2
This is a chart displaying the estimated probability of response to Frovatriptan Succinate tablets 2.5 mg and Placebo at various intervals of time since initial dose. The probability of response ranges from 100% to 0%.*
Figure 2 - frovatriptan succinate 3
This appears to be a chart displaying the estimated probability of remedication or rescue for a medication named "frovatriptan succinate tablets 2.5mg" compared to a placebo. The chart shows percentages ranging from 100% to 0%, with time increments ranging from 4 to 24 hours since the initial dose.*
Principal Display Panel - 2.5 mg Carton - frovatriptan succinate 4
This is a product description for Frovatriptan Succinate Tablets. The tablets contains 3.91 mg frovatriptan succinate, which is equivalent to 2.5 mg of frovatriptan. The tablets come in a blister card of nine tablets. The product is stored at 25°C (77°F) and can withstand excursions permitted to 15-30°C (59'-86'F). The product is manufactured by Almac Pharma Services Limited in Craigavon, BT63 5UA, UK and marketed by Par Pharmaceutical in Chestnut Ridge, NY 10977.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.